Disease Group Invests in Do-It-Yourself Drugs
- 9 June 2000
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 288 (5472) , 1715-1717
- https://doi.org/10.1126/science.288.5472.1715b
Abstract
On 31 May, the Cystic Fibrosis (CF) Foundation of Bethesda, Maryland, announced that it will invest at least $30 million in a small biotech firm, Aurora Biosciences of San Diego, to identify compounds that might prove useful in treating CF. This project, fueled initially by a donation of $20 million from the Bill and Melinda Gates Foundation, marks a new departure in the growing trend of patient groups taking charge of biomedical research.Keywords
This publication has 0 references indexed in Scilit: